This episode delves into the clinical efficacy and safety of cerebrospinal fluid (CSF) shunting for hydrocephalus caused by leptomeningeal metastases (LMM). Based on the abstract of a systematic review and meta-analysis published in World Neurosurgery in 2026, we explore the quantitative synthesis of functional outcomes, symptom improvement, and complication rates associated with ventriculoperitoneal, lumboperitoneal, and other CSF diversion procedures in this patient population. Understand the current evidence regarding the benefits and risks of shunting in managing elevated intracranial pressure and neurological deficits secondary to LMM. This information is intended for medical professionals and is not a substitute for clinical judgment. This content is for informational purposes only and does not constitute medical advice.